Browse the evidence

GLP-1 receptor agonists (liraglutide 3 mg and semaglutide 2.4 mg) produce significantly greater weight loss in patients with obesity compared to orlistat, with average losses of 7 kg more than control groups in meta-analyses.

If you have obesity and a related health condition (like diabetes or high blood pressure), GLP-1 medications (liraglutide or semaglutide) are significantly more effective for weight loss than older drugs like orlistat. You must combine the medication with a healthy diet and exercise. Start with the lowest dose and increase slowly to minimize stomach upset, which usually goes away.

Consuming a twice-daily protein-polyphenol beverage (post-exercise and pre-bed) during the early phase of resistance training (first 10 sessions) increases daily myofibrillar protein synthesis rates and accelerates early muscle functional gains compared to a placebo.

If you are just starting resistance training, adding a protein-polyphenol supplement twice a day (after workouts and before bed) can help your muscles repair and function better in the first few weeks. This involves a specific blend of whey/pea/casein protein with pomegranate extract post-workout, and casein with tart cherry extract before bed. This strategy speeds up early strength gains and protein synthesis, though it may not change long-term muscle size compared to standard protein.

Supplementing with 25g whey protein and 4000 IU vitamin D3, consumed either before bedtime or in the morning after sleep, significantly increases total lean tissue mass and leg lean tissue mass in young males undergoing resistance training compared to a placebo.

If you are a young man starting resistance training and you know you are low in Vitamin D, take 25g of whey protein mixed with 4000 IU of Vitamin D3 every day. It does not matter if you take it in the morning or right before bed; just take it daily alongside your training. This combination will help you build more muscle mass than training alone.

Telephonic behavioral coaching combined with web-based self-monitoring (weight, calories, exercise) is perceived as highly helpful and effective for weight loss across diverse demographic groups, including older adults, Black individuals, and those with lower education levels.

Use a remote weight loss program that includes weekly phone calls with a coach and a website to track your weight, food, and exercise. This combination is highly effective and well-liked, especially if you are older, Black, or have less formal education. You don't need to rely solely on your doctor's advice; the coach and the tracking tools provide the accountability you need.

GLP-1 receptor agonists (GLP-1RAS) significantly reduce body weight and improve glucose tolerance in prediabetic patients, offering a potent alternative to metformin, particularly for those with obesity.

GLP-1 receptor agonists (like semaglutide or liraglutide) are injectable medications that significantly reduce weight and improve blood sugar in prediabetes. They are particularly effective for overweight individuals. Side effects like nausea are common initially. They are more potent than metformin for weight loss but require injection.

Vitamin D supplementation (≥ 1000 IU/day) reduces the risk of developing diabetes in individuals with prediabetes by improving insulin sensitivity and beta-cell function.

If you have prediabetes, check your Vitamin D levels. Supplementation with ≥ 1000 IU/day can significantly reduce your risk of developing diabetes by improving insulin sensitivity. Monitor calcium levels to avoid hypercalcemia.

Obesity is a modifiable risk factor for pancreatic cancer (PC), with a 5-unit BMI increase associated with an 8-12% rise in PC risk.

Maintaining a healthy weight, especially around the abdomen, is important for reducing your risk of pancreatic cancer. Obesity is linked to an 8-12% increase in risk for every 5-unit increase in BMI.

Achieving a weight loss of 10% or greater is required to induce type 2 diabetes remission and prevent microvascular disease, chronic kidney disease progression, cardiovascular events, and overall mortality.

To potentially reverse type 2 diabetes and protect your kidneys and heart, aim to lose more than 10% of your body weight. This is a significant amount of weight and is difficult to achieve and maintain through diet and exercise alone due to your body's natural drive to regain weight. You likely need high-efficacy medical interventions (like GLP-1/GIP agonists or bariatric surgery) or intensive lifestyle programs to reach this threshold. Focus on reducing visceral fat and improving adipose tissue function, not just hitting a specific BMI number.

GLP-1 receptor agonists produce significant weight loss (average 1.5–3 kg) in patients with type 2 diabetes, whereas DPP-4 inhibitors have a neutral effect on body weight.

If you have type 2 diabetes, GLP-1 receptor agonists (like liraglutide or exenatide) are likely to help you lose 1.5–3 kg, which is a modest but clinically relevant benefit. DPP-4 inhibitors (like sitagliptin) will not help you lose weight, but they also won't make you gain it. The choice depends on your specific health profile and preference for oral vs. injectable medication.

Higher attendance at lifestyle coaching sessions is significantly associated with greater weight loss, suggesting that the ineffectiveness of the moderate-intensity program is driven by low adherence rather than the intervention content itself.

If you are enrolled in a lifestyle coaching program, your attendance is the most critical factor for success. This study shows that each additional coaching session leads to more weight loss. If you find yourself missing appointments, the program will likely fail, not because the advice is bad, but because you aren't receiving the full 'dose' of support. Prioritize keeping your appointments.

Physical activity provides significant health benefits and aids in weight maintenance independent of, and often superior to, diet-induced weight loss alone, refuting the notion that one 'cannot outrun a bad diet'.

Do not rely on diet alone for long-term health or weight management. While diet is effective for short-term weight loss, physical activity is essential for maintaining that loss and provides unique health protections (e.g., against hypertension, diabetes, cancer) that persist even if your weight doesn't change. Prioritize regular movement as a non-negotiable component of health, regardless of your dietary choices.

Intensive, multicomponent lifestyle intervention (diet, exercise, behavioral counseling) remains foundational and synergistic with anti-obesity medications (GLP-1 RAs), improving outcomes and mitigating side effects, whereas relying on medication alone without lifestyle support may lead to suboptimal results and higher discontinuation.

Do not skip lifestyle changes just because you are taking weight-loss medication. Combine your medication with a structured plan involving diet, exercise, and behavioral counseling. This approach maximizes your weight loss, helps you keep the weight off, and can reduce medication side effects like nausea. Aim for 200-300 minutes of moderate exercise per week and attend intensive counseling sessions (at least 12 in the first year).

Tirzepatide, a dual GIP/GLP-1 receptor agonist administered as a once-weekly injection, produces significantly greater weight loss and glycemic control in adults with obesity and type 2 diabetes compared to placebo, semaglutide, and long-acting insulin analogs.

If you have obesity and Type 2 Diabetes, standard diet and exercise may not be enough to control your blood sugar or achieve significant weight loss. Tirzepatide is a once-weekly injection that targets both GLP-1 and GIP hormones to improve insulin response, reduce appetite, and slow digestion. Clinical data shows it leads to greater weight loss than placebo, semaglutide, and insulin analogs. However, it carries risks of gastrointestinal side effects (nausea, vomiting) and is contraindicated for those with a history of medullary thyroid cancer. Consult a doctor to see if this high-efficacy intervention is appropriate for your specific health profile.

Whey protein supplementation (25 g/day for 13 days) significantly reduces exercise-induced muscle damage, as measured by serum creatine kinase (CK) levels, in older adults following prolonged walking, whereas pea protein supplementation at the same dose does not.

If you are over 60 and engage in long-distance walking, whey protein (25g/day) may help reduce muscle damage markers more effectively than pea protein. Ensure you consume it consistently for at least 13 days, starting before your activity.

Whole food meals produce significantly higher feelings of fullness compared to both gluten-free and ultra-processed meals, despite similar macronutrient content.

To stay full longer, prioritize whole foods over processed or gluten-free alternatives. This study showed that whole food meals led to significantly higher feelings of fullness than both processed and gluten-free meals, even when calories and macros were identical. Choosing whole foods can help manage hunger without needing to reduce portion sizes.

Lifestyle interventions for type 2 diabetes prevention in women with a history of gestational diabetes are significantly more effective when initiated within one year postpartum.

If you have a history of gestational diabetes, start your lifestyle changes (diet and exercise) within the first year after giving birth. Waiting longer significantly reduces the effectiveness of these changes in preventing type 2 diabetes. Early action during this critical window offers the best protection.

Electronic or mobile delivery of lifestyle interventions (websites, phone, text) results in greater body weight reduction in women with a history of gestational diabetes compared to face-to-face only delivery.

If you have a history of gestational diabetes and want to lose weight, consider using electronic or mobile lifestyle interventions (websites, phone, text messages). These methods have been shown to result in greater weight loss compared to face-to-face only interventions.

Cluster training with 20-second intra-set rest intervals and 3-repetition maximum blocks significantly increases lower-limb fat-free mass and strength in resistance-trained men, with no additional benefit from extending rest to 40 seconds.

If you are a trained male lifter, try cluster training with 20-second rests between blocks of 3 reps. This approach significantly boosts strength and lower-body muscle mass. You do not need to rest 40 seconds between blocks for extra gains; 20 seconds is sufficient and more time-efficient. Ensure you are eating enough calories and protein to support these adaptations.

Weight reduction of 5-10% improves metabolic risk factors, while reduction of ≥10-15% consistently improves sleep apnea, reduces new-onset type 2 diabetes, and reduces overall mortality.

Aim for a 5-10% weight loss to improve metabolic markers, and 10-15% or more to significantly impact sleep apnea and mortality. Focus on sustainable energy balance rather than specific diet dogmas, as weight loss itself is the primary driver of remission for conditions like T2DM.

Physical activity of ≥5000 steps per day is a reasonable initial goal for obesity management, with ≥10,000 steps associated with greater weight reduction.

Start with 5000 steps per day. This is achievable and offers health benefits. If you can increase to 10,000 steps, you may see greater weight loss. Use walking as a tool for maintenance and metabolic health, not just calorie burning.

Weight loss of at least 5-10% significantly lowers systolic and diastolic blood pressure in obese individuals, and this effect is independent of the specific weight loss strategy used.

Achieving a 5-10% weight loss can significantly lower blood pressure (5-20 mmHg systolic). This benefit is achieved regardless of the method used (diet, exercise, or medication). Targeting at least 10% weight loss is recommended for most patients to see meaningful improvements in obesity-related complications.

Subcutaneous tirzepatide is the most cost-effective anti-obesity medication for adults without diabetes over a 68-week period, demonstrating superior incremental cost-effectiveness compared to oral semaglutide, subcutaneous semaglutide, and subcutaneous liraglutide.

For adults without diabetes seeking weight loss, subcutaneous tirzepatide offers the best value for money among current GLP-1 based therapies over a 68-week period. It is more cost-effective than oral semaglutide, subcutaneous semaglutide, and subcutaneous liraglutide. While oral semaglutide is a good alternative for those who dislike injections, tirzepatide provides superior cost-effectiveness. Patients should discuss these options with their healthcare provider, considering factors like injection preference, insurance coverage, and potential side effects.

Resistance exercise extends the duration of the muscle protein synthesis response to protein ingestion, thereby allowing for greater cumulative muscle growth compared to protein ingestion alone.

To maximize muscle growth, you must combine resistance exercise with protein intake. Exercise extends the time your muscles are sensitive to protein (up to 24-48 hours). Simply eating protein without exercising will not build muscle; the protein will be used for energy instead.

A daily caloric deficit of at least 600 kcal, achieved through dietary intervention, is the foundational mechanism for sustainable weight loss and can induce type 2 diabetes remission.

To lose weight, you must consume fewer calories than you burn. Aim for a daily deficit of 600 kcal. You can achieve this through various diets (Mediterranean, low-carb, etc.), but the key is choosing one you can sustain. If you have type 2 diabetes, a more aggressive low-energy diet under medical supervision may help achieve remission.